The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-carbamimidoyl-4-(4-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)benzylideneamino)benzenesulfonamide ID: ALA4870827
PubChem CID: 164624298
Max Phase: Preclinical
Molecular Formula: C20H21N7O5S
Molecular Weight: 471.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncc([N+](=O)[O-])n1CCOc1ccc(/C=N\c2ccc(S(=O)(=O)NC(=N)N)cc2)cc1
Standard InChI: InChI=1S/C20H21N7O5S/c1-14-23-13-19(27(28)29)26(14)10-11-32-17-6-2-15(3-7-17)12-24-16-4-8-18(9-5-16)33(30,31)25-20(21)22/h2-9,12-13H,10-11H2,1H3,(H4,21,22,25)/b24-12-
Standard InChI Key: CZDXMOVGCZWZDQ-MSXFZWOLSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
7.1773 -16.2613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9944 -16.2613 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.5858 -15.5536 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7599 -16.2612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4229 -15.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1685 -15.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3513 -15.0025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0969 -15.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3201 -16.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2046 -16.0367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8127 -15.4908 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3733 -16.8362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7599 -17.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4676 -17.4870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4676 -18.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1753 -18.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1728 -19.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8797 -19.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5884 -19.5310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5857 -18.7096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8783 -18.3047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2966 -19.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0038 -19.5291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0027 -18.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7094 -18.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7087 -17.4894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9999 -17.0809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2904 -17.4948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2946 -18.3099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7043 -15.8532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7059 -15.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4143 -14.6288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9989 -14.6261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
7 8 2 0
5 6 2 0
4 5 1 0
6 7 1 0
8 4 1 0
8 9 1 0
10 11 2 0
10 12 1 0
5 10 1 0
4 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
27 2 1 0
2 30 1 0
30 31 1 0
31 32 1 0
31 33 2 0
M CHG 2 10 1 12 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.50Molecular Weight (Monoisotopic): 471.1325AlogP: 2.10#Rotatable Bonds: 9Polar Surface Area: 178.59Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: ┄HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.75CX Basic pKa: 6.34CX LogP: 2.08CX LogD: 2.04Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.18Np Likeness Score: -1.64
References 1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM.. (2021) Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective., 210 [PMID:33234343 ] [10.1016/j.ejmech.2020.112994 ]